Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Xinyi Wanxiang Pharmaceutical
Shanghai, Shanghai, Chinasine-wx.com ↗
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
The company holds over 180 product approvals, with a strong commercial presence in China and international markets (notably South Africa, Southeast Asia). Products and clinical programs span cardiovascular, anti-infective, metabolic, digestive, nervous system, and dermatology, with focus on solid and soft capsule formulations. Four drug approvals are noted, indicating mature manufacturing and market presence.
- Therapeutic areas
- EndocrinologyGastroenterologyCardiovascularOncologyNeurology
- Modalities
- Small moleculeBiologic
- Industry
- Pharma
02
Partnerships
Distribution and approvals in South Africa and Southeast AsiaPotential ties to CanSino for vaccine manufacturing via parent group
Beyond the preview
Go deeper on Shanghai Xinyi Wanxiang Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Xinyi Wanxiang Pharmaceutical.